Molecular Insight has developed a new biopharmaceutical to detect heart attacks. Company's unique approach to the protection of intellectual property uses Hatch Waxman Act and orphan drugs. The company is trying to raise $ 7 million in funding for Series B. Whether it should continue its current strategy or change your approach? Includes color exhibits.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Richard G. Hamermesh Source: Harvard Business School 23 pages. Publication Date: January 12, 2005. Prod. #: 805067-PDF-ENG
Related Case Solutions & Analyses:
Building a Community at Semiconductor Manufacturing International Corporation
The Coronet-Leslie Forsyte
Health Resources & Technology
Implementing Electronic Road Pricing in Singapore: Epilogue (Sequel)
Apple Computer–John Sculley Chairman & CEO–Presentation to ISMP Participants July 6 1992 Video
Acumen Fund: How to Make the Greatest Impact
Event sponsorship and ambush marketing: Lessons from the Beijing Olympics
Woodmere Properties, Inc.
Rushway Brothers Lumber and Building Supplies (RLBS)
H. J. Heinz M&A
